\"Our next step is that we're going to offer vaccination to our school students, the teenagers, following which it'll be open season for everyone in Singapore,\" said Foreign Minister Vivian Balakrishnan

Sotrovimab will be available for appropriate patients diagnosed with COVID-19 in the US in the coming weeks and discussions with global regulators regarding authorisations in additional countries continue to advance, said GSK

Responding to a question on whether Bharat Biotech would be open to make the production of Covaxin open to other entities, Ella said this might not be the best way forward

Share of Brigade Enterprises opened with a gain of 13.68% at Rs 283.40 on BSE

Share of Tata Motors touched an intraday low of Rs 312.15 , down 6.08% against previous close of  Rs 332.35 on BSE

Stocks in news: Axis Bank, Tata Motors, Central Bank, GSK Pharma, Minda Corp and more

During a daily virtual press briefing on Monday, the World Health Organisation Director-General said that the surge in COVID-19 cases around the world has compromised the global vaccine supply

China fully understands and is supportive of the developing world's demand for an IPR waiver for COVID-19 vaccines, Chinese Foreign Ministry spokesman Zhao Lijian told reporters in Beijing, without directly referring to India and South Africa's proposal

Govt committee has completed an in-depth case review of 498 serious and severe events, of which 26 cases were reported to have potential thromboembolic events. No such events were reported after administration of Covaxin vaccine

Monday's announcement, however, comes as a relief for Sanofi and GSK after they were forced last December to restart their trial and delay the launch of the shot when the vaccine showed a low immune response in older adults as a result of a weak antigen formulation

For January-March quarter, HUL's net profit grew 41 per cent to Rs 2,143 crore, while sales rose 34 per cent YoY to Rs 11,947 crore.

World Health Organisation (WHO)'s data on 'Landscape of candidate vaccines in clinical development' says a total of 91 vaccine candidates have reached the clinical development stage

The Board of Directors of GlaxoSmithKline Pharmaceuticals approved the sale of the manufacturing facility

Business Today awards in Chennai saw Tamil Nadu CM Edappadi K. Palaniswami announce investments worth Rs 10 lakh crore, creating employment opportunities for 20 lakh people over next four years

Business Today on Tuesday honoured companies, business leaders based in Tamil Nadu, who contributed to the growth of the state. The winners were identified on the basis of the difference they made in the state, by a high profile jury comprising Arun Roy, IAS, Special Secretary, Industries Department, Govt of Tamil Nadu; Dr Darez Ahmed, IAS, Executive Director, Guidance Tamil Nadu; Preetha Reddy, Vice-Chairperson Apollo Hospitals Group; Rajshree Pathy, Chairperson, Rajshree Sugars & Chemicals; Dr GSK Velu, CMD, Trivitron & Neuberg Diagnostics and Chairman, Ficci Tamil Nadu State Council; Prof Pawan Kumar Singh, Director, IIM Trichy and N Madhan, Regional Managing Partner-South, PwC India. The Chief Minister of Tamil Nadu, Thiru Edappadi K Palaniswami, presented a total of 11 awards, including five for investment, three for employment, one for exports and two for others. Watch the video for more.Also Read: BT Business Leaders of TN: Manufacturing, electronics, SaaS can make India $5 trillion economy, say experts

Business Today Tamil Nadu Business Leaders of State Awards 2021: Hyundai Motor bagged the Biggest FDI Investment in Tamil Nadu, while Cheyyar SEZ Developers took away the Biggest Employer in Tamil Nadu award

In December last year, Sanofi had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data

Stock Market Live News Today: Sensex and Nifty continued hitting new all-time highs today. Both benchmarks hit fresh lifetime highs of 51,523 and 15,159 earlier today

HUL Q3 results: The revenue from operations stood at Rs 11,682 crore, up 20.48 per cent YoY and 3.6 per cent quarter-on-quarter (QoQ)

Details on the size of the deal or the price per dose COVAX would pay were not immediately clear, but the sources said the allotment would likely be relatively small